PRESS RELEASE June 15, 2017

Immune Pharmaceuticals Signs Agreement to Regain Worldwide Rights for Ceplene

Immune’s subsidiary, Cytovia, plans commercialization activities in Europe and Latin America NEW YORK, June 15, 2017 /PRNewswire/ — Immune Pharmaceuticals Inc. (NASDAQ: IMNP) (‘Immune’) announced today that it has signed an agreement with Meda, a Mylan NV company (‘Mylan’) to repurchase assets relating to Ceplene, including the right to commercialize Ceplene in Europe and to register and commercialize Ceplene in […]

Keep Reading